CDTX vs CL
Cidara Therapeutics Inc (CDTX) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
CDTX currently screens at market cap $6.96B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the CDTX and CL stock pages for the full models.
Not investment advice.